Asston Pharmaceuticals Limited, incorporated in 2019 and based in Navi Mumbai, is a pharmaceutical company primarily engaged in manufacturing and exporting pharmaceutical formulations and nutraceutical products. The company operates under the brand “Asston” and supplies to both domestic and international markets, with a strong presence in African countries like Sierra Leone, Ghana, and Liberia, and upcoming registration in Asian markets like Cambodia and Vietnam.
🔬 Products Offered
- Dosage Forms: Tablets, Capsules, Syrups, Ointments, Creams, Gels, Lotions, and Sachets (Dry Syrup, Oral Powder)
- Therapeutic Categories: Analgesics, Antibiotics, Antifungals, Vitamins, and more.
- Products are manufactured:
- For direct sale under its own brand
- On a contract manufacturing (loan license) basis for other marketers (principle-to-principle model)
🏭 Manufacturing Facility
- Located at Ambernath, Maharashtra
- Separate sections for pharmaceuticals (FDA compliant) and nutraceuticals (FSSAI compliant)
- Capacity:
- Tablets: ~8–9 crore per month (avg. 5–6 crore currently)
- Syrups: ~37.5 kilolitres/month
- Sachets: 30–40 lakh/month
🌐 Certifications
- Certified by Central and State FDA
- Complies with Quality Management Systems (QMS)
- Accredited by NQA
💼 Sales & Marketing
- Focus on supplying to pharmacies and distributors across Africa
- Emphasis on:
- Competitive pricing
- High-quality compliance
- Participation in expos and trade fairs
- Merchandise branding and promotional events
📦 Operational Strengths
- Broad product range across therapeutic segments and age groups.
- Flexible packaging sizes for varied customer needs.
- Strong customer retention driven by quality, timely delivery, and feedback-driven improvements.
Asston Pharmaceuticals IPO – Details
| IPO Opening Date | 09 July 2025 |
| IPO Closing Date | 11 July 2025 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue: 22,41,000 Shares Worth ₹27.56 Crore Fresh Issue: 22,41,000 Shares Worth ₹27.56 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹115 – ₹123 per share |
| Market Lot | 1000 Shares |
| Min Order | 1000 Shares ( 1 Lot ) |
| Listing At | BSE SME |
| Registrar | Maashitla Securities Private Limited |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Asston Pharmaceuticals IPO – Date Schedule
| IPO Open Date | 09 July 2025 |
| IPO Close Date | 11 July 2025 |
| Basis of Allotment | 14 July 2025 |
| Initiation of Refund | 15 July 2025 |
| Credit of Shares to Demat | 15 July 2025 |
| IPO Listing Date | 16 July 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 11, 2025 |
Asston Pharmaceuticals IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2000 | ₹2,46,000 |
| Retail (Max) | 2 | 2000 | ₹2,46,000 |
| HNI (Min) | 3 | 3000 | ₹3,69,000 |
Competitive Strengths
- Formulation Expertise.
- Experienced Promoters.
- Wide range of Products.
- Strategic Location.
- Skilled Workforce.
Company Promoters
- Dr. Ashish Narayan Sakalkar
- Saili Jayaram More
- Sachin Chandrakant Badakh
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowings |
|---|---|---|---|---|
| 31 March 2023 | ₹7.19 Cr | ₹5.78 Cr | ₹1.06 Cr | ₹5.25 Cr |
| 31 March 2024 | ₹15.84 Cr | ₹14.02 Cr | ₹1.36 Cr | ₹6.82 Cr |
| 31 March 2025 | ₹25.61 Cr | ₹19.91 Cr | ₹4.33 Cr | ₹7.26 Cr |
| 31 May 2025 | ₹6.21 Cr | ₹4.44 Cr | ₹1.32 Cr | ₹7.83 Cr |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 50.56% |
| ROCE | 51.25% |
| Debt/Equity | 0.68 |
| RoNW | 40.36% |
| PAT Margin | 17.27% |
| EBITDA Margin | 24.60% |
| Price to Book Value | 12.07 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 6.90 | 9.32 |
| P/E (x) | 17.83 | 13.20 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Funding capital expenditure requirements for acquiring machinery in the manufacturing unit. | ₹6.00 |
| Funding the incremental working capital requirements of the Company. | ₹13.00 |
| Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company. | ₹1.00 |
| General Corporate Purposes |
Asston Pharmaceuticals IPO Peer Comparison
| S.No. | Face Value | Company Name | P/E |
|---|---|---|---|
| 1 | 10 | Shelter Pharma Limited | 6.70 |
| 2 | 10 | Bafna Pharmaceuticals Limited | 51.38 |
| 3 | 10 | Trident Lifeline Limited | 25.29 |
✅Strengths
- Wide product range like tablets, syrups, capsules.
- Strong export base in Africa, expanding to Asia.
- Certified by FDA, FSSAI, and NQA.
- Flexible manufacturing and packaging.
- Owns multiple trademarks across products.
⚠️Risks
- Heavy reliance on exports to few countries.
- Strict and changing pharma regulations.
- Limited track record (started in 2019).
- Forex rate fluctuations affect profits.
- High competition in generic medicine market.
Asston Pharmaceuticals IPO Promoter Holding
| Pre Issue Share Holding | 68.76% |
| Post Issue Share Holding | 50.66% |
Asston Pharmaceuticals IPO Prospectus
Company Contact Information
| Asston Pharmaceuticals Limited 4th Floor, Office No. A-431 Balaji Bhavan, Plot No 42A Sector-11 CBD Belapur, Navi Mumbai, Thane Navi Mumbai, Maharashtra, 400614 Phone: +91 22 49731411 Email: info@asstonpharmaceuticals.com Website: http://www.asstonpharmaceuticals.com/ |
Asston Pharmaceuticals IPO Registrar
| Maashitla Securities Private Limited Phone: +91-11-45121795-96 Email: ipo@maashitla.com Website: https://maashitla.com/allotment-status/public-issues |
Asston Pharmaceuticals IPO Lead Manager(s)
| 1. Sobhagya Capital Options Ltd |
Asston Pharmaceuticals IPO FAQ
| What is Asston Pharmaceuticals IPO? Asston Pharmaceuticals IPO is a SME IPO. The issue is priced at ₹115 to ₹123 per equity share. The IPO is to be listed on BSE SME. |
| When Asston Pharmaceuticals IPO will open? The IPO is to open on 09 July 2025 for QIB, NII, and Retail Investors. |
| What is Asston Pharmaceuticals IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| How to Apply the Asston Pharmaceuticals IPO? You can apply Asston Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Asston Pharmaceuticals IPO through Angle One? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Angle One. |
| How to Apply the Asston Pharmaceuticals IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals IPO“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Asston Pharmaceuticals IPO through Upstox? Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox. |
| How to Apply the Asston Pharmaceuticals IPO through IIFL? Log in to IIFL Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals IPO“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with IIFL. |
| What is the Asston Pharmaceuticals IPO Size? Asston Pharmaceuticals IPO size is ₹27.56 Crore. |
| What is the Asston Pharmaceuticals IPO Price Band? Asston Pharmaceuticals IPO Price Band is ₹115 to ₹123. |
| What is Asston Pharmaceuticals IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 2000 Shares with ₹2,46,000 amount, while the maximum bid is 2000 Shares with ₹2,46,000. |
| What is the Asston Pharmaceuticals IPO Allotment Date? Asston Pharmaceuticals IPO allotment date is 14 July 2025. |
| What is the Asston Pharmaceuticals IPO Listing Date? Asston Pharmaceuticals IPO listing date is 16 July 2025. The IPO is to be listed on the BSE SME. |
